Skip to main content

Table 1 :

From: The use of high-dose azidothymidine in combination with chemotherapy upfront is an effective treatment approach for gamma-herpes virus-related non-Hodgkin’s lymphomas

Age Lymphoma type Stage PS HIV CD4 Alternating regimen RT Sustained Response (months) Progression (months) Death (months)
34 DLBCL IVB 3 + 4 - - PD 1.0 1.3
49 BL IVB 2 + 91 EPOCH - CR (50) - -
40 BL IIA 2 - - hCVAD + CR (57) - -
51 DLBCL IVB 2 + 47 EPOCH - CR (65) - -
40 BL IVB 2 + 214 hCVAD - PD 2.0 -
34 PBL IVB 2 + 16 - - PD 1.0 4.5
33 PBL IIA 1 + 166 EPOCH - CR (18) - -
44 PBL IVA 1 + 458 EPOCH - CR (19) - -
52 PBL IIB 1 + 57 EPOCH + CR (20) - -
51 Solid PEL IVB 2 + 113 - - CR (31), 2nd CR (10) After 1st line: 31.1 -
  1. PS: ECOG performance score; RT: radiotherapy; DLBCL: diffuse large B-cell lymphoma; PEL: primary effusion lymphoma; PBL: plasmablastic lymphoma. EPOCH: etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin; hyper cVAD: dexamethasone and fractionated vincristine, doxorubicin cyclophosphamide; CR: complete remission; PR: partial remission; PD: progressive disease.